Tervonen Hanna E, Walton Richard, You Hui, Baker Deborah, Roder David, Currow David, Aranda Sanchia
School of Health Sciences, Centre for Population Health Research, University of South Australia, GPO Box 2471, Adelaide, SA, 5001, Australia.
Information Analysis Unit, Cancer Institute NSW, GPO Box 41, Alexandria, Sydney, NSW, 1435, Australia.
BMC Cancer. 2017 Jun 2;17(1):398. doi: 10.1186/s12885-017-3374-6.
Aboriginal and Torres Strait Islander peoples in Australia have been found to have poorer cancer survival than non-Aboriginal people. However, use of conventional relative survival analyses is limited due to a lack of life tables. This cohort study examined whether poorer survival persist after accounting for competing risks of death from other causes and disparities in cancer stage at diagnosis, for all cancers collectively and by cancer site.
People diagnosed in 2000-2008 were extracted from the population-based New South Wales Cancer Registry. Aboriginal status was multiply imputed for people with missing information (12.9%). Logistic regression models were used to compute odds ratios (ORs) with 95% confidence intervals (CIs) for 'advanced stage' at diagnosis (separately for distant and distant/regional stage). Survival was examined using competing risk regression to compute subhazard ratios (SHRs) with 95%CIs.
Of the 301,356 cases, 2517 (0.84%) identified as Aboriginal (0.94% after imputation). After adjusting for age, sex, year of diagnosis, socio-economic status, remoteness, and cancer site Aboriginal peoples were more likely to be diagnosed with distant (OR 1.30, 95%CI 1.17-1.44) or distant/regional stage (OR 1.29, 95%CI 1.18-1.40) for all cancers collectively. This applied to cancers of the female breast, uterus, prostate, kidney, others (those not included in other categories) and cervix (when analyses were restricted to cases with known stages/known Aboriginal status). Aboriginal peoples had a higher hazard of death than non-Aboriginal people after accounting for competing risks from other causes of death, socio-demographic factors, stage and cancer site (SHR 1.40, 95%CI 1.31-1.50 for all cancers collectively). Consistent results applied to colorectal, lung, breast, prostate and other cancers.
Aboriginal peoples with cancer have an elevated hazard of cancer death compared with non-Aboriginal people, after accounting for more advanced stage and competing causes of death. Further research is needed to determine reasons, including any contribution of co-morbidity, lifestyle factors and differentials in service access to help explain disparities.
研究发现,澳大利亚原住民和托雷斯海峡岛民的癌症生存率低于非原住民。然而,由于缺乏生命表,传统的相对生存分析方法的应用受到限制。这项队列研究探讨了在考虑其他死因导致的死亡竞争风险以及诊断时癌症分期差异之后,总体所有癌症以及按癌症部位划分时,较差的生存率是否仍然存在。
从基于人群的新南威尔士癌症登记处提取2000年至2008年被诊断出的患者。对信息缺失的患者(12.9%)多重填补原住民身份信息。使用逻辑回归模型计算诊断时“晚期”(分别针对远处转移和远处/区域转移分期)的比值比(OR)及95%置信区间(CI)。使用竞争风险回归分析生存率,计算亚风险比(SHR)及95%CI。
在301,356例病例中,2517例(0.84%)被确定为原住民(填补后为0.94%)。在调整年龄、性别、诊断年份、社会经济地位、居住偏远程度和癌症部位后,总体所有癌症中,原住民被诊断为远处转移(OR 1.30,95%CI 1.17 - 1.44)或远处/区域转移分期(OR 1.29,95%CI 1.18 - 1.40)的可能性更高。这适用于女性乳腺癌、子宫癌、前列腺癌、肾癌、其他癌症(未包含在其他类别中的癌症)以及宫颈癌(当分析仅限于已知分期/已知原住民身份的病例时)。在考虑其他死因导致的死亡竞争风险、社会人口学因素、分期和癌症部位后,原住民的死亡风险高于非原住民(总体所有癌症的SHR为1.40,95%CI 1.31 - 1.50)。一致的结果适用于结直肠癌、肺癌、乳腺癌、前列腺癌和其他癌症。
在考虑更晚期分期和其他死因后,患癌的原住民与非原住民相比,癌症死亡风险更高。需要进一步研究以确定原因,包括合并症、生活方式因素以及服务可及性差异等方面的任何作用,以帮助解释这些差异。